According to a report by FitsNews, bipartisan senators in South Carolina have voted to pass a bill proposing to ban the sale of all e-cigarette devices except for a few select types. This bill would increase enforcement of existing FDA regulations at the state level. The bill (S.994) would only allow retailers in South Carolina to sell devices that are currently FDA-approved, while temporarily allowing the sale of devices that are under federal official or court review.
Supporters of the bill cited the need to protect children from nicotine addiction in the state, while opponents believed that the legislation would benefit big tobacco companies and be a loss for adults who wish to quit smoking using e-cigarettes.
However, many tobacco industry giants support FDA regulation because the agency's mass rejections of their competitors can ensure that existing, well-resourced players maintain dominance in the market. If the legal case in South Carolina becomes law, new entrants will be prohibited from selling products in the state.
If the bill is passed in the House of Representatives, the e-cigarette registration bill in South Carolina will enter the state's House of Representatives research agenda.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
